Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27853326)
Watch
English
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
PubMed ID
26789870
retrieved
13 November 2016
title
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
(English)
1 reference
stated in
PubMed
PubMed ID
26789870
retrieved
13 November 2016
main subject
biomarker
0 references
colon cancer
1 reference
based on heuristic
inferred from title
author
Piero Dalerba
object named as
Piero Dalerba
series ordinal
1
0 references
Soonmyung Paik
object named as
Soonmyung Paik
series ordinal
3
0 references
Xiangqian Guo
object named as
Xiangqian Guo
series ordinal
4
0 references
Matt van de Rijn
series ordinal
17
object named as
Matt van de Rijn
0 references
author name string
Debashis Sahoo
series ordinal
2
0 references
Greg Yothers
series ordinal
5
0 references
Nan Song
series ordinal
6
0 references
Nate Wilcox-Fogel
series ordinal
7
0 references
Erna Forgó
series ordinal
8
0 references
Pradeep S Rajendran
series ordinal
9
0 references
Stephen P Miranda
series ordinal
10
0 references
Shigeo Hisamori
series ordinal
11
0 references
Jacqueline Hutchison
series ordinal
12
0 references
Tomer Kalisky
series ordinal
13
0 references
Dalong Qian
series ordinal
14
0 references
Norman Wolmark
series ordinal
15
0 references
George A Fisher
series ordinal
16
0 references
Michael F Clarke
series ordinal
18
0 references
language of work or name
English
0 references
publication date
21 January 2016
0 references
published in
The New England Journal of Medicine
0 references
volume
374
0 references
issue
3
0 references
page(s)
211-22
0 references
cites work
Single-cell dissection of transcriptional heterogeneity in human colon tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
20 March 2017
Phenotypic characterization of human colorectal cancer stem cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
20 March 2017
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
20 March 2017
Homeosis and intestinal tumours in Cdx2 mutant mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
20 March 2017
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Adjuvant chemotherapy for stage II colon cancer with poor prognostic features
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
The role of Cdx genes in the gut and in axial development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Boolean implication networks derived from large scale, whole genome microarray datasets
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Extracting binary signals from microarray time-course data
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Systemic therapy for colorectal cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
CDX-2, a new marker for adenocarcinoma of gastrointestinal origin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
29 September 2017
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
2 June 2018
A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
Demonstration of CDX2 is highly antibody dependant
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4784450
retrieved
27 November 2018
Chemotherapy: Is adjuvant chemotherapy an option for stage II colon cancer?
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26789870
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Molecular profiles and clinical outcome of stage UICC II colon cancer patients
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26789870
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Ongoing challenge of stage II colon cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26789870
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Stage II colon cancer prognosis prediction by tumor gene expression profiling
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26789870
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26789870
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1056/NEJMOA1506597
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
391083
OpenCitations bibliographic resource ID
391083
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
391083
PMCID
4784450
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
391083
PubMed ID
26789870
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
391083
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
